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Background
The cytochrome P450 2C9 and 3A5 enzymes are predo-
minantly found in the human liver, and have important
functions in the metabolism of antiepileptics. Genetic
polymorphisms in these genes are associated with
altered enzymatic activities and may give rise to the risk
of drug hypersensitivity. Therefore, we analyze the asso-
ciation between CBZ hypersensitivity reactions (CHR)
and polymorphisms of CYP2C9 and 3A5 in a population
of São Paulo, Brazil.
Methods
Case-control study in which we genotyped the SNP of
CYP2C9 (rs1057910, rs1799853) and 3A5 (rs776746) of
samples obtained from 52 subjects with varying severities
CHR, 82 tolerants, and 366 control subjects, all from São
Paulo, Brazil. According to the alleles presente, each sub-
ject was classified as normal, decrease or increased funcion
for the enzyme. The phenotype was evaluated based on
standardized scoring systems using an adapted ENDA
(European Network of Drug Allergy) questionnaire, medi-
cal records and on the clinical follow-up. The patch test
with the culprit drug was performed according the ENDA
recommendations.
Results
We studied 500 subjects, 52 were validated as CHR, 28
Drug Reaction with DRESS and 14 SJS. Sixty-five percent
of females and mean age was 43.6 years. Eighty percent
had mixed ethinicity. Of all 41 drug patch tests, 28 (68%)
were positive, in both SJS and DRESS. We found a strong
association between normal activity of CYP3A5 and
tolerants subjects when compared to CHR (p=0.0002
OR=4.8), but we observed homogeneous distribution of
variants of CYP2C9 in our case and control groups.
None of our groups presented positive association with
CYP2C9 polymorphisms.
Conclusion
Based on the association of the polymorphism of CYP3A5
and the tolerant group, we hypothesize that it can contri-
bute to the tolerability of anti-epileptics. We could not
find an association between CYP2C9 polymorphisms in
any of these subjects, different from the previously
described in different populations. Given the rarity of such
reactions, more work is needed to translate observed dif-
ferences in metabolism and pharmacokinetics into using
genomic variation for predictive use.
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